| Identification | |
| Name: | 17-Oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione,7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-,(1S,3S,7S,10R,11S,12S,16R)- |
| Synonyms: | AzaepothiloneB; BMS 247550; BMS 247550-1; Ixabepilone; Ixempra |
| CAS: | 219989-84-1 |
| Molecular Formula: | C27H42 N2 O5 S |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.122g/cm3 |
| Refractive index: | 1.532 |
| Solubility: | In water, 0.69 mg/L at 25 deg C (est) |
| Specification: |
?Ixabepilone , its cas register number is 219989-84-1. It also can be called Ixabepilone [INN] ; S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione ; Azaepothilone B ; 17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)- .It is?an epothilone B analog, and it has developed by Bristol-Myers Squibb as a cancer drug. Also, it acts to stabilize microtubules. |
| Color: | Colorless oil or white lyopholizate |
| Safety Data | |
 |
|
